Hepatitis B surface antigen recombinant - medicine shortage information

Back to CRITICAL Shortages     Back to ALL Shortages

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist. In most cases your doctor and pharmacist will know about the possible substitute medicines to continue your care.

In some cases the Supply Detail section below will provide information about the special arrangements that are in place for your health professional to prescribe or supply a substitute medicine. These may include reference to Special Access Scheme or "Under section 19A"

Product details Supply Impact Dates Further Details
H-B-VAX II hepatitis B vaccine recombinant 10 microgram/1mL injection pre-filled syringe (thiomersal free)
AUST R: 127245
Active ingredients:
Hepatitis B surface antigen recombinant

Sponsor:
Merck Sharp & Dohme (Australia) Pty Ltd

Phone:
1800642865

From
22 Aug 2017
to
31 Jan 2021

Status:
Current

Patient impact:
Medium

Availability:
Unavailable

Reason:
Manufacturing

TWINRIX (combined hepatitis A & hepatitis B vaccine) 1 mL injection pre-filled syringe thiomersal & preservative free
AUST R: 140575
Active ingredients:
Hepatitis a virus antigen
Hepatitis B surface antigen recombinant

Sponsor:
GlaxoSmithKline Australia Pty Ltd

Phone:
1800033109

From
15 Feb 2019
to
01 Jul 2019

Status:
Current

Patient impact:
Medium

Availability:
Limited Availability

Reason:
Manufacturing

TGA Management Actions:
18/02/19 The sponsor is closely controlling the supply.

H-B-VAX II hepatitis B vaccine recombinant preservative-free paediatric 5 microgram/0.5mL injection pre-filled syringe
AUST R: 127244
Active ingredients:
Hepatitis B surface antigen recombinant

Sponsor:
Merck Sharp & Dohme (Australia) Pty Ltd

Phone:
1800 642 865

From
01 Oct 2019
to
30 Jun 2020

Status:
Anticipated

Patient impact:
Medium

Availability:
Available

Reason:
Manufacturing

H-B-VAX II hepatitis B vaccine recombinant 40 microgram/1mL injection vial (thiomersal free)
AUST R: 90623
Active ingredients:
Hepatitis B surface antigen recombinant

Sponsor:
Merck Sharp & Dohme (Australia) Pty Ltd

Phone:
1800 642 865

From
01 Jun 2019
to
31 Jul 2021

Status:
Anticipated

Patient impact:
Medium

Availability:
Available

Reason:
Manufacturing

TWINRIX JUNIOR (combined hepatitis A & hepatitis B vaccine) 0.5 mL injection pre-filled syringe thiomersal & preservative free
AUST R: 140576
Active ingredients:
Hepatitis a virus antigen
Hepatitis B surface antigen recombinant

Sponsor:
GlaxoSmithKline Australia Pty Ltd

Phone:
1800033109

From
31 May 2019
to
01 Jul 2019

Status:
Anticipated

Patient impact:
Medium

Availability:
Available

Reason:
Manufacturing